Many advanced formulations use both peptides together for complementary benefits
On the EPIC Study website, it specifically states: "Currently there is no treatment licensed to delay the onset of CHF [congestive heart failure]." Elsewhere on the EPIC Study website it states: "There is currently no treatment licensed for the management of preclinical, myxomatous mitral valve disease (MMVD)." And still on another page of the EPIC Study website it states: "Treatment of CHF due to MMVD begins when the dog shows clear clinical signs of heart failure, and is tailored for the individual dog." As you see, pimobendan's own manufacturer repeatedly warns against giving the drug to dogs before they are in heart failure
Your cart is empty Browse our collection to find what you need
Peptide research blend (GHRH analogue + ghrelin-receptor agonist) 99%+ purity (HPLC) Store lyophilised at 20 C, protect from light Pre-filled injection pen For laboratory research use only
Your prescribing doctor can often recommend trusted compounding pharmacies they have worked with
Nephrology, Dialysis, Transplantation